Home > Clinical Trials

Saved trials

Recruiting
NCT05359224
Low Dose Prasugrel vs Clopidogrel for Stenting or Flow Diverter for Unruptured Aneurysm
406 Enrollment(s)
1 Study location(s)
Interventional (Phase IV)
Intracranial Aneurysm
Recruiting
NCT03568890
Short-Term Anticoagulation Versus Antiplatelet Therapy for Preventing Device Thrombosis Following Left Atrial Appendage Closure
350 Enrollment(s)
1 Study location(s)
Interventional (Phase IV)
Left Atrial Appendage Closure
Thrombosis
Stroke
TIA
Bleeding
Active, not recruiting
NCT04519944
Edoxaban in Patients With Non-valvular Atrial Fibrillation Undergoing Percutaneous Coronary Intervention
1,200 Enrollment(s)
66 Study location(s)
Observational
Non-valvular Atrial Fibrillation
Completed
NCT04459598
A Study of the Effect of a Moderate CYP3A Inducer Efavirenz on Quizartinib Pharmacokinetics in Healthy Participants
32 Enrollment(s)
1 Study location(s)
Interventional (Phase I)
Healthy Subjects
Drug-drug Interaction
Pharmacokinetics
Quizartinib
Recruiting
NCT05320627
Population Pharmacokinetics of Edoxaban in Chinese Patients With Non-Valvular Atrial Fibrillation
120 Enrollment(s)
1 Study location(s)
Interventional (Phase IV)
Non-Valvular Atrial Fibrillation
Completed
NCT04608344
Study to Evaluate Organic Anion Transporting Polypeptide (OATP) Transporter-Mediated Drug-Drug Interactions Between Filgotinib and Statins as Probe Drugs in Healthy Participants
27 Enrollment(s)
1 Study location(s)
Interventional (Phase I)
Rheumatoid Arthritis
Completed
NCT01536964
The Effect of Morphine on Prasugrel Absorption in STEMI Patients
12 Enrollment(s)
1 Study location(s)
Interventional (Phase IV)
Cardiovascular Disease
Terminated
NCT04209725
A Study of CPX-351 (Vyxeos™) With Quizartinib for the Treatment of FLT3-ITD Mutation-Positive Acute Myeloid Leukemia
1 Enrollment(s)
5 Study location(s)
Interventional (Phase II)
Leukemia, Myeloid, Acute